| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $34.1M | -20.1% | -19.5% |
| SG&A Expense | $18.4M | -26.7% | -32.3% |
| Operating Income | -$52.2M | +26.6% | +24.7% |
| Interest Expense | $473K | +0.0% | +0.4% |
| Net Income | -$50.3M | +27.0% | +24.6% |
| EPS (Basic) | -$0.45 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $75.9M | +131.4% | +15.8% |
| Short-term Investments | $146.8M | -38.5% | -13.7% |
| Current Assets | $227.7M | -17.9% | -5.8% |
| Total Assets | $368.0M | -12.6% | -6.5% |
| Current Liabilities | $31.2M | -28.2% | -22.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$155.2M | — | — |
| Capital Expenditures | $360K | — | — |
| Investing Cash Flow | $67.3M | — | — |
| Financing Cash Flow | $148K | — | — |
| Free Cash Flow | -$155.5M | — | — |
| +36.6% |
| EPS (Diluted) | -$0.45 | +27.4% | +36.6% |
| $54.4M |
| -18.6% |
| -14.9% |
| Stockholders' Equity | $313.7M | -11.4% | -4.9% |